Vaccinia Virus News and Research

RSS
The vaccinia virus is the "live virus" used in the smallpox vaccine. It is a "pox"-type virus related to smallpox. When given to humans as a vaccine, it helps the body to develop immunity to smallpox. The smallpox vaccine does not contain the smallpox virus and it cannot cause smallpox.
Oral bacteria-based SARS-CoV-2 vaccine platform

Oral bacteria-based SARS-CoV-2 vaccine platform

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Vaccinia-based COVID-19 vaccines confer immunity in hamster model

Vaccinia-based COVID-19 vaccines confer immunity in hamster model

CDC monitoring over 200 individuals possibly exposed to monkeypox

CDC monitoring over 200 individuals possibly exposed to monkeypox

Researchers review environmental risk assessments for recombinant COVID-19 viral vector vaccines

Researchers review environmental risk assessments for recombinant COVID-19 viral vector vaccines

Vaccines delivered via skin may offer better protection against respiratory diseases

Vaccines delivered via skin may offer better protection against respiratory diseases

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study

Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study

Disinfectants with "virucidal activity against enveloped viruses" effective against SARS-CoV-2

Disinfectants with "virucidal activity against enveloped viruses" effective against SARS-CoV-2

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Modified Vaccinia Ankara-based vaccine candidate for SARS-CoV-2

Modified Vaccinia Ankara-based vaccine candidate for SARS-CoV-2

A first-in-human trial with promising MERS coronavirus vaccine

A first-in-human trial with promising MERS coronavirus vaccine

GlobalData: China can use the lessons learnt from SARS epidemic to control Wuhan coronavirus

GlobalData: China can use the lessons learnt from SARS epidemic to control Wuhan coronavirus

Scientists solve 3D structure of vaccinia virus RNA polymerase

Scientists solve 3D structure of vaccinia virus RNA polymerase

Cells form cage-like structures that trap viruses, find scientists

Cells form cage-like structures that trap viruses, find scientists

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

Oncolytic virus alerts the immune system to attack tumors

Oncolytic virus alerts the immune system to attack tumors

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

New study examines immune responses to Ebola vaccines at one year after immunization

New study examines immune responses to Ebola vaccines at one year after immunization

Scientists discover critical role of biological molecule in protecting against infection

Scientists discover critical role of biological molecule in protecting against infection